Royalty Pharma plc
RPRX
$32.74
-$0.615-1.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.10B | 987.23M | 998.55M | 1.80B | 872.00M |
| Total Receivables | 740.34M | 810.73M | 790.67M | 773.68M | 682.71M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.08M | 4.19M | 4.97M | 2.29M | 5.01M |
| Total Current Assets | 1.84B | 1.80B | 1.79B | 2.58B | 1.56B |
|
|
|||||
| Total Current Assets | 1.84B | 1.80B | 1.79B | 2.58B | 1.56B |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.32M | 5.32M | 5.32M | 5.32M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.06B | 15.16B | 15.01B | 13.91B | 13.47B |
| Total Assets | 17.61B | 18.22B | 18.04B | 17.66B | 16.13B |
|
|
|||||
| Total Accounts Payable | 37.63M | 13.37M | 22.06M | 23.42M | 11.55M |
| Total Accrued Expenses | 19.22M | 98.06M | 38.41M | 56.25M | 12.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 998.61M | 997.77M | 996.94M | -- | -- |
| Total Finance Division Other Current Liabilities | 127.40M | 144.41M | 110.35M | 196.03M | 100.43M |
| Total Other Current Liabilities | 127.40M | 144.41M | 110.35M | 196.03M | 100.43M |
| Total Current Liabilities | 1.18B | 1.25B | 1.17B | 275.70M | 124.57M |
|
|
|||||
| Total Current Liabilities | 1.18B | 1.25B | 1.17B | 275.70M | 124.57M |
| Long-Term Debt | 6.62B | 6.61B | 6.61B | 7.60B | 6.14B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.90M | 12.08M | 5.58M | 27.04M | 3.22M |
| Total Liabilities | 7.82B | 7.88B | 7.78B | 7.90B | 6.27B |
|
|
|||||
| Common Stock & APIC | 4.21B | 4.10B | 4.11B | 4.10B | 4.07B |
| Retained Earnings | 2.48B | 2.85B | 2.76B | 2.38B | 2.43B |
| Treasury Stock & Other | -2.65M | -2.66M | -2.66M | -2.66M | -2.65M |
| Total Common Equity | 6.69B | 6.95B | 6.87B | 6.48B | 6.50B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.69B | 6.95B | 6.87B | 6.48B | 6.50B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 3.10B | 3.40B | 3.39B | 3.28B | 3.36B |
| Total Equity | 9.79B | 10.34B | 10.26B | 9.75B | 9.86B |
|
|
|||||